Nachrichten und Videos - EASTON PHARMS INC

TORONTO, June 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Easton Pharmaceuticals Inc. (OTC: EAPH ) (“Easton” or “the Company”) announces it has filed its quarterly report for the three months ended March 31, 2019, and provides several key updates on its business initiatives. Q1 Filing In the first quarter of 2019, Easton Pharmaceuticals recorded revenues of $612,689 and turned from a loss to post net income of $7,878. Revenues were generated from the Company’s contract with a...

TORONTO, ON / ACCESSWIRE / April 30, 2019 / Easton Pharmaceuticals, Inc. (OTC PINK: EAPH ) executive management is pleased to announce the move of its corporate head office from Elm Street, Toronto, Ontario to Brockhouse Road, Toronto, Ontario. Easton confirms that with the acquisition of Supreme Sweets Inc. the management will be joining the Easton team at the Brockhouse Road facility and adding the extensive product line up to its growing product group within the Company's Food and Beverage...

TORONTO, ON / ACCESSWIRE / April 24, 2019 / Easton Pharmaceuticals, Inc. (the "Company" or "Easton") (OTC PINK: EAPH ) is pleased to announce that it has now officially closed on its acquisition of a food processing company based in Toronto, Canada. Easton has completed its acquisition of Supreme Sweets Inc. and 2498411 Ontario Inc. (collectively the "Acquiree"), which includes all the tangible and intangible assets of the company such as equipment, intellectual property (patents, trade secrets,...

TORONTO, ON / ACCESSWIRE / April 12, 2019 / Easton Pharmaceuticals, Inc. (OTC PINK: EAPH ) provides update on the closing of its agreement to acquire a commercial bakery with existing revenues and projected to reach over $20,000,000 within 12 months. Easton announced earlier this week that its legal counsel believed that all documents would be completed this week with signatures and exchange of documents. Due to schedule conflicts between legal counsel, the official closing has been re-scheduled...

TORONTO, ON / ACCESSWIRE / April 8, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH ) provides update on the closing of its agreement to acquire a commercial bakery with existing revenues and projected to reach over $20,000,000 within 12 months. Easton announced earlier in March that it had signed a Definitive Agreement to acquire a commercial bakery and food preparation company with existing revenues and projected revenues in excess of $20,000,000 over the next 12 months. Easton's legal...

TORONTO, ON / ACCESSWIRE / April 2, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH ) Announces that is has signed a Joint Venture Agreement for the purchase and development of 9 townhomes in Welland, Ontario and provides update on its ongoing contract for the framing of 150 homes in Whitby, Ontario. Easton is pleased to have signed a joint venture agreement for the purchase and development of 9 townhomes in Welland, Ontario, which is less than 30 minutes from Niagara Falls, Canada. The...

TORONTO, ON / ACCESSWIRE / March 27, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH ) announces that it has signed a Letter of Intent with a Licensed Producer of Medical Marijuana in Canada, whereby Easton will participate in the LP's expansion plans. In its ongoing efforts to diversify and enter into other lucrative sectors, Easton is pleased to announce that it has signed a Letter of Intent with a Canadian Licensed Producer of Cannabis, already in revenues from its cultivation and sales...

TORONTO, ON / ACCESSWIRE / March 18, 2019 / Easton Pharmaceuticals, Inc. (OTC PINK: EAPH ) Announces that it has filed its Financial Statements for the Year Ended December 31, 2018 and provides general updates on Its business initiatives. Easton realized revenues of $378,589 USD during 2018, an increase in revenues over 145% from 2017. The Company's revenues primarily derived during the last 2 quarters from activities generated from its Georgina property, as well as from its construction...

TORONTO, ON / ACCESSWIRE / March 13, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH ) Provides Update on Its $2,600,000 CDN framing contract to build approximately 150 homes just outside of Toronto, Ontario, including an update on its development project to construct upto 42 new homes on an approximately 2.7 acres property it recently acquired in Cobourg, Ontario. Easton recently announced that it has entered into a $2,600,000 CDN framing contract and has commenced work on the framing of...

TORONTO, ON / ACCESSWIRE / March 11, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH ) announces that it has commenced the set-up of a Cannabis Edibles division, pursuant to its acquisition of a commercial bakery and food production facility. Easton has entered into discussions with several Licensed Producers in Canada to develop a line of Cannabis Edibles that can be sold through the LP's, as well as through the existing distribution channels of the commercial bakery and food processing...

TORONTO, ON, March 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) announces that it has signed an agreement to acquire a commercial bakery with existing revenues and projected to reach over $20,000,000 within 12 months. In its ongoing efforts to diversify and enter other lucrative sectors and add value-added businesses to achieve consistent growing sales to coincide with its revenue-generating framing contract and its pharmaceutical / diagnostic...

Toronto, ON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) Provides Operational Update on its $2,600,000 CDN framing contract to build approximately 150 homes just outside of Toronto, Ontario. Easton recently announced that it has entered into a $2,600,000 CDN framing contract and has commenced work on the framing of approximately 150 homes with a well-known prominent regional builder. The contract is well underway and is expected to be completed...

TORONTO, ON, Jan. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) announces completion of its financial statements with $200,000 in sales in its quarter ending September 30 th and just over $200,000 in sales booked in its last quarter ending December 31, 2018. Easton is pleased to have achieved what it believes to be consistent sales through its various operations. Easton currently owns approximately 3 acres in Cobourg, Ontario, just 1 hour east of the...

TORONTO, ON, Jan. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Easton Pharmaceuticals Inc. (OTC: EAPH) provides operational update on its $2,600,000 CDN framing contract to build approximately 150 homes just outside of Toronto, Ontario including possible new project. Easton recently announced that it has entered into a $2,600,000 CDN framing contract and has commenced work on the framing of approximately 150 homes with a well-known prominent regional builder. Easton can disclose that it has...

TORONTO, ON, Jan. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) Announces that it has closed on a Construction Agreement and has started operations on a $2,600,000 CDN framing contract to build approximately 150 homes just outside of Toronto, Ontario. As part of its plan to enter more lucrative market segments and become a more diversified company, Easton through the efforts of its director Vince Demasi, is pleased to announce that it has entered into...

TORONTO, ON, Dec. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) announces that it has closed on an Agreement to acquire a Real Estate Development Project just outside of Toronto, Ontario with 3 year cumulative profits expected to exceed $30,000,000 Canadian. As part of its plan to enter more lucrative market segments, Easton is pleased to announce that it has now completed its purchase of a development property in Cobourg, Ontario, a growing lakefront...

TORONTO, ON, Dec. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) Provides Company update including Hotel Acquisition in Toronto, BAYER Distribution Agreement for Mexico, as well as the Casino and Hotel Resort acquisition in Greece. As previously announced, Easton through the efforts of its CEO, Evan Karras and his personal involvement with a hotel / development property / project, located in the heart of downtown Toronto, Canada, is currently in the...

TORONTO, ON, Oct. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) announces that it has made it to the short-list to acquire an interest or participate in the acquisition of Club Hotel Casino Loutraki, a 5 Star casino and hotel resort in Greece. The resort comprises of a private beach, 255 rooms and 20 suites, 8 restaurants, a wellness center, conference facilities and an 87 table/1,000 slot machine casino plus a VIP area. The casino and hotel resort is...

TORONTO, ON, Sept. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) is pleased to announce that it has reached an agreement on the main terms to take over an operating boutique hotel and real estate asset in the heart of Toronto, Ontario, Canada. After several weeks of negotiations, Easton has reached a consensus on the main terms that will form the final agreement whereby Easton will take ownership of an operating Boutique Hotel located on Bay Street in...